CDH3 and glioblastoma: We identified GBM cells with high (SNB19, GBML18, GBML24, and GBML45), intermediate (A172, GBML26, GBML42, and GBML95), and low/undetectable CDH3 expression (U87MG, U373MG, U251MG, and LN229), nicely recapitulating the heterogeneity observed in patients.